Assessment of Wiskott-Aldrich syndrome in survivors following allogeneic BMT for Wiskott-Aldrich syndrome
| Disease status . | HLA-identical sibling donor (n = 48) . | Other related donor (n = 25) . | Unrelated donor (n = 47) . |
|---|---|---|---|
| Cured | 30 (73%) | 12 (57%) | 22 (73%) |
| Improved | 8 (20%) | 5 (24%) | 8 (27%) |
| Unchanged | 3 (7%) | 1 (5%) | 0 (0%) |
| Worse | 0 (0%) | 3 (14%) | 0 (0%) |
| Not reported | 7 | 4 | 17 |
| Disease status . | HLA-identical sibling donor (n = 48) . | Other related donor (n = 25) . | Unrelated donor (n = 47) . |
|---|---|---|---|
| Cured | 30 (73%) | 12 (57%) | 22 (73%) |
| Improved | 8 (20%) | 5 (24%) | 8 (27%) |
| Unchanged | 3 (7%) | 1 (5%) | 0 (0%) |
| Worse | 0 (0%) | 3 (14%) | 0 (0%) |
| Not reported | 7 | 4 | 17 |